• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic study highlights sex-based disparities in post-stroke cardiac care

Medtronic study highlights sex-based disparities in post-stroke cardiac care

February 10, 2025 By Sean Whooley

This image shows the logo of Medtronic.Medtronic (NYSE: MDT) announced study findings highlighting significant disparities in cardiac care following stroke.

The DiVERT Stroke clinical study showed that women spent less time in the hospital, saw fewer referrals to cardiology, and were prescribed less frequent post-stroke cardiac monitoring than men when admitted to comprehensive stroke centers following stroke. Investigators presented data last week at the International Stroke Conference (ISC) in Los Angeles.

Medtronic says multiple studies show patients at high risk of AFib post-stroke. In many cases, it can take more than 80 days for AFib to appear, highlighting the need for long-term, insertable cardiac monitoring (ICM). While previous studies demonstrated disparities in stroke care for women compared to men, Medtronic says the full extent remains understudied.

More about the Medtronic post-stroke cardiac care analysis

DiVERT Stroke examined in-hospital care pathways for patients with cryptogenic, large-vessel atherosclerotic disease and small vessel disease stroke subtypes.

A retrospective analysis from DiVERT Stroke found that, among 2,699 patients, female patients (48% of the study participants) were less likely than male patients to receive cardiology referrals during index hospitalization (12.8% vs. 15.5%). Female patients also had a shorter length of stay (6.8 days vs. 7.7 days). They also proved less likely to receive post-stroke cardiac monitoring (19.9% vs. 23%).

Additionally, AFib rate detected post-stroke came in higher for any type of cardiac monitoring vs. non-cardiac monitoring, irrespective of sex. The study saw no sex differences for type of cardiac monitoring (external vs. insertable cardiac monitors).

Medtronic plans for DiVERT Stroke Phase II to evaluate opportunities to improve workflow deficiencies. That includes referral pathways, potentially helping to minimize disparities in care.

“Women have a higher lifetime risk of stroke compared to men, and yet these findings suggest that when it comes to post-stroke care, women are seeing cardiology less often and getting less cardiac monitoring care than their male counterparts,” said Dr. David Z. Rose, professor of vascular neurology at University of South Florida Morsani College of Medicine at Tampa General Hospital and lead investigator in the DiVERT Stroke study who presented the data at the meeting.  “Standardizing care pathways between neurology and cardiology is one way to help ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke. Further research on this topic is needed and may include artificial intelligence (AI) solutions.”

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Implants, Neurological, Patient Monitoring, Structural Heart, Vascular Tagged With: Medtronic

More recent news

  • Zimmer Biomet, Think Surgical extend exclusive distribution agreement
  • Cambridge Heartwear inks £184M deal to supply NHS with portable ECG monitors
  • J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
  • California and Massachusetts still reign as top US medtech headquarters locations
  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy